COL1A1 Is a Potential Prognostic Biomarker and Correlated with Immune Infiltration in Mesothelioma

Figure 6

The COL1A1 expression and mutation in MESO tissues from the cbioportal database. (a) The expression of COL1A1 across 27 kinds of cancers. (b) COL1A1 genetic alteration in MESO using reverse-phase protein arrays (RPPA).

(a)

(b)